Genmab A/SGMABNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank14
3Y CAGR-47.9%
5Y CAGR-35.0%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-47.9%/yr
vs +26.9%/yr prior
5Y CAGR
-35.0%/yr
Recent deceleration
Acceleration
-74.8pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 10.23% |
| 2024 | 30.67% |
| 2023 | 13.57% |
| 2022 | 72.33% |
| 2021 | -16.75% |
| 2020 | 88.43% |
| 2019 | 77.38% |
| 2018 | 27.89% |
| 2017 | 30.25% |
| 2016 | 60.29% |